Literature DB >> 28488054

[Choosing wisely recommendations in rheumatology : One year after their first publication].

E Märker-Hermann1, A J Voormann2.   

Abstract

Almost 1 year after publication of the Choosing wisely recommendations ("Klug-entscheiden-Empfehlungen," KEE) for rheumatology, it is evident that they have found their way into specialist and lay publications, the media used by self-help groups, online media, and continuing education congresses. As such, a broad target audience has been reached. In the meantime, newly established or updated guidelines have been published which incorporate the KEE for rheumatology. The KEE provide a gateway into clinical Standard Operating Procedures or recommendations.

Entities:  

Keywords:  Colchicine; Communications media; Giant cell arteritis; Guidelines as topic; Low back pain

Mesh:

Year:  2017        PMID: 28488054     DOI: 10.1007/s00108-017-0247-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

1.  Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.

Authors:  W Shi; S A Krilis; B H Chong; S Gordon; C N Chesterman
Journal:  Aust N Z J Med       Date:  1990-06

Review 2.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

3.  Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period.

Authors:  Nobuhide Hayashi; Masahiro Koshiba; Kunihiro Nishimura; Daisuke Sugiyama; Tomoko Nakamura; Sahoko Morinobu; Seiji Kawano; Shunichi Kumagai
Journal:  Mod Rheumatol       Date:  2008-02-19       Impact factor: 3.023

4.  Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study.

Authors:  Matthew D Morgan; Jennifer Turnbull; Umut Selamet; Manvir Kaur-Hayer; Peter Nightingale; Charles J Ferro; Caroline O S Savage; Lorraine Harper
Journal:  Arthritis Rheum       Date:  2009-11

5.  Rheumatoid arthritis is an independent risk factor for an increased augmentation index regardless of the coexistence of traditional cardiovascular risk factors.

Authors:  Herwig Pieringer; Tobias Brummaier; Michael Schmid; Max Pichler; Avida Hayat-Khayyati; Stefan Ebner; Georg Biesenbach; Erich Pohanka
Journal:  Semin Arthritis Rheum       Date:  2012-04-03       Impact factor: 5.532

6.  European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.

Authors:  W Zhang; M Doherty; T Bardin; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; E Pascual
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

7.  Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.

Authors:  Thomas H Taylor; John N Mecchella; Robin J Larson; Kevin D Kerin; Todd A Mackenzie
Journal:  Am J Med       Date:  2012-11       Impact factor: 4.965

8.  The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.

Authors:  Ulla R C Lindqvist; Gerd-Marie Alenius; Tomas Husmark; Elke Theander; Gunilla Holmström; Per T Larsson
Journal:  J Rheumatol       Date:  2008-02-15       Impact factor: 4.666

9.  [Vaccination in adult patients with chronic inflammatory rheumatic diseases].

Authors:  S Goldacker; A M Gause; K Warnatz
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

Review 10.  Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.

Authors:  Kunihiro Nishimura; Daisuke Sugiyama; Yoshinori Kogata; Goh Tsuji; Takashi Nakazawa; Seiji Kawano; Katsuyasu Saigo; Akio Morinobu; Masahiro Koshiba; Karen M Kuntz; Isao Kamae; Shunichi Kumagai
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

View more
  1 in total

Review 1.  [Characteristics of pharmacotherapy in older patients with rheumatism].

Authors:  H-J Lakomek; Christian Schulz
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.